市場調查報告書
商品編碼
1258837
到 2028 年的蝦青素市場預測 - 按產品(油、液體、軟膠囊、幹藻粉或生物質)、來源(天然和合成)、生產技術、應用和地區分列的全球分析Astaxanthin Market Forecasts to 2028 - Global Analysis By Product (Oil, Liquid, Softgel and Dried Algae Meal or Biomass), Source (Natural and Synthetic), Production Technology, Application and By Geography |
根據 Stratistics MRC 的數據,2022 年全球蝦青素市場規模將達到 8.642 億美元,預計到 2028 年將達到 16.516 億美元,預測期內增長 11.3%。預計以 % 的 CAGR 增長。
蝦青素是一種稱為類胡蘿蔔素的分子,存在於某些海洋動植物中。 植物的顏色來自一類稱為類胡蘿蔔素的色素。 藻類中富含作為營養補充劑原料的蝦青素。 一些海鮮被蝦青素染成紅色或粉紅色。 蝦青素是一種抗氧化劑,有助於降低人體內的氧化水平。 因此,生產商正在使用蝦青素生產功能性食品和其他商品,這有望刺激全球市場增長。
根據中國漁業報告,中國仍然是世界上最大的海產品生產國,產量為6549萬噸。 據印度品牌資產基金會 (IBEF) 稱,印度製藥業預計將在美國產生 550 億美元的銷售額。
對有機食品的需求不斷增加,這主要是因為消費者認為有機食品比傳統食品更安全、更健康。 消費者對有機食品和天然色素的健康益處的認識不斷提高,導致人們越來越偏愛天然色素而不是合成色素。 消費者健康意識的增強和對環保產品的偏好不斷增長,正在推動市場需求。
蝦青素產品的批准指南非常嚴格。 為了推出一種藥物,公司必須遵守眾多國家和國際法規。 政府對這些化合物的消費施加的限制和法規阻礙了含有蝦青素的食品和飲料的使用,從而延長了這些物質的批准過程。 然而,阻礙市場擴張的因素之一是由於原材料短缺導致的高製造成本。
水產養殖、人類和動物都可以從蝦青素作為膳食補充劑中獲益。 蝦青素因其抗氧化、著色和促進健康的特性而被廣泛用於飼料添加劑和醫藥行業。 越來越多的證據表明,由於蝦青素在皮膚生物學中的多種集體功能,它在皮膚病學中具有許多健康益處和重要的膳食補充劑應用。 這些因素正在推動市場的增長。
由於蝦青素的雜質含量高,環境、人類和動物都處於嚴重危險之中。 與植物不同,動物不能自行產生蝦青素,因此它們必須從飲食中獲取。 此外,由於蝦青素是從微藻中提取的,因此成本高且耗時長,這使得天然蝦青素的開發極為困難。 因此,雜質污染已成為市場增長的主要挑戰。
COVID-19 疫情增加了消費者對含蝦青素產品的需求。 由於冠狀病毒導致免疫系統減弱,許多醫生認為天然蝦青素是一種有效的抗氧化和抗炎成分,可加速恢復並增強腸道菌群和患者的整體健康狀況。推薦使用 肥胖症的增加也增加了消費者對蝦青素食品補充劑的偏好,眾所周知,蝦青素食品補充劑可以促進新陳代謝並減少消化系統中的毒素。 這對行業環境產生了積極影響。
由於對藻類蝦青素的需求不斷增加,預計幹藻粉或生物質行業將實現有利增長。 如此高的份額是由於其廣泛的可用性。 天然來源包括磷蝦油和 Xantho-phyllomyces dendrorhous。 在其他配方的生產中使用生物質、對下游加工的需求最少、動物飼料的高可用性以及大規模生產的便利性是該細分市場增長的主要驅動力。這是一個因素。
由於對膳食補充劑中天然蝦青素的需求不斷增加,而且蝦青素比其他食品補充劑具有更好的抗氧化特性,因此預計膳食補充劑行業在預測期內增長最快,預計將以復合年增長率增長。 此外,不健康的生活方式、快速衰老和必需營養素攝入不足正在推動對營養補充劑的需求。
由於活躍消費者的存在,亞太地區預計在預測期內將佔據最大的市場份額。 高未滿足的需求、蝦青素產量的增加、研發支出的增加以及經濟的擴張是推動該地區對這些產品需求的主要因素。是一個因素。 此外,城市化進程的加快、可支配收入的增加以及對天然蝦青素興趣的增加預計將推動該地區的市場。
由於與營養和皮膚相關的疾病日益流行,預計北美在預測期內的複合年增長率最高。 預計該市場將受到快速城市化、較高的消費者可自由支配收入水平以及對天然產品日益增長的興趣的推動。 此外,大量注重健康的人、越來越多地採用營養補充劑以及成熟的化妝品行業是推動該地區市場增長的關鍵因素。
蝦青素市場的主要參與者包括:BASF SE、北京銀杏集團、Koninklijke DSM N.V.、Cyanotech Corporation、Atacama Bio Natural Products S.A.、ENEOS Corporation、Algalif Iceland ehf、Fuji Chemical Industry Co., Ltd., Algatech Ltd, Digi Laboratories Ltd., Beijing Gingko Group, DSM NV, JXTG Japan Oil & Energy Co., Ltd., Algaecan Biotech Ltd., Griffon Co., Ltd. and Stanley Black & Decker Inc..
2020 年 10 月,Cyanotech Corporation 推出了 1% 和 2% 濃度的水分散性粉末形式的 BioAstin。 它是一種自由流動型,可以分散在熱水和冷水中。
2019 年 5 月,Algatech LTD 推出了一種微膠囊天然蝦青素粉,專為視覺和大腦健康而配製。 這將使公司能夠響應新的細分市場並增加其在市場上的影響力。
購買此報告的客戶將免費獲得以下定制之一。
According to Stratistics MRC, the Global Astaxanthin Market is accounted for $864.2 million in 2022 and is expected to reach $1,651.6 million by 2028 growing at a CAGR of 11.3% during the forecast period. A molecule called a carotenoid, astaxanthin is present in some marine plants and animals. Plants receive their colour from a class of pigment called carotenoid. Astaxanthin, which can be used as a source for dietary supplements, is abundant in algae. Some seafood are coloured red or pink by astaxanthin. Antioxidant astaxanthin aids in lowering oxidation levels in the human body. As a result, producers are using astaxanthin in the production of functional foods and other goods, which is anticipated to stimulate the growth of the worldwide market.
According to China's Fishery Report, China remained the world's largest seafood producer with a production of 65.49 million metric tons. According to India Brand Equity Foundation (IBEF), Indian pharmaceuticals industry is expected to generate US $55 billion.
Organic food demand is always rising, largely as a result of consumer perceptions that organic food is safer and healthier than conventional food. Due to growing consumer awareness of organic products and the advantages of natural food colours for health, natural food colours are increasingly preferred over synthetic food colours. Consumers increasing health awareness and increased preference for environmentally friendly items are fueling market demand.
Astaxanthin product approval guidelines are very strict. To release their drug, companies must abide by numerous national and international regulations. The use of food and beverages containing astaxanthin has been impeded by government-imposed restrictions and regulations regarding the intake of these compounds, which prolong the approval process of these substances. However, one of the factors impeding market expansion is the high production cost caused by the scarcity of raw materials.
Aquaculture, humans, and animals can all benefit from astaxanthin as a nutritional supplement. Astaxanthin has been widely employed in feed additives and the medical industry because of its antioxidant, colouring, and health-promoting properties. There is mounting evidence that astaxanthin, because of its diverse collective functions in skin biology, offers a number of health benefits and important nutraceutical uses in dermatology. These factors are propelling the growth of the market.
The environment, people, and animals are all in grave peril from adulterated astaxanthin. Animals, unlike plants, cannot generate astaxanthin on their own and must consume it through diet. Furthermore, due to its expensive and labor-intensive production procedure from microalgae, natural astaxanthin may be extremely difficult to develop. Thus, adulteration poses a significant challenge to the growth of the market.
The COVID-19 epidemic increased consumer demand for astaxanthin-containing goods. Many medical professionals recommended using natural astaxanthin since it is an effective anti-oxidant and anti-inflammatory ingredient that speeds up recovery and boosts patients' gut and overall health as a result of the corona virus' weakening effects on immune systems. Also, the rising prevalence of obesity increased consumer preference for astaxanthin food supplements, which are known to promote metabolism and decrease toxins in the digestive system. This had a favourable impact on the industry environment.
The dried algae meal or Biomass segment is estimated to have a lucrative growth, due to the growing demand for algal astaxanthin. Such a high share is due to its wide availability. Few of its natural sources include Krill oil, and Xantho-phyllomyces dendrorhous. The use of biomass for the production of other formulations, the necessity of minimal downstream processing, higher use as animal feed, and convenient bulk production are some key factors driving the segment's growth.
The nutraceuticals segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the increased demand for natural astaxanthin in nutritional products and better antioxidant properties of astaxanthin than other available food supplements. In addition, unhealthy lifestyles, a rapidly aging population, and insufficient intake of essential nutrients are propelling the demand for nutraceuticals.
Asia Pacific is projected to hold the largest market share during the forecast period owing to the presence of highly proactive consumers. High unmet demands, rising astaxanthin production in the area, rising R&D spending, and economic expansion are some of the main factors driving up demand for these items in the area. Also, it is projected that rising urbanisation, high disposable income, and rising interest in natural astaxanthin will boost the market in this region.
North America is projected to have the highest CAGR over the forecast period, owing to the increasing prevalence of nutrition & skin-related diseases. The market is expected to be driven by rapid urbanisation, high consumer discretionary income levels, and rising interest in natural products. Furthermore, a large number of health-conscious people, an increase in the adoption of nutraceuticals, and a well-established cosmeceutical industry are some of the major factors accelerating market growth in the region.
Some of the key players profiled in the Astaxanthin Market include: BASF SE, Beijing Ginko Group, Koninklijke DSM N.V., Cyanotech Corporation, Atacama Bio Natural Products S.A., ENEOS Corporation, Algalif Iceland ehf, Fuji Chemical Industries Co., Ltd, Algatech Ltd, Divi Laboratories Ltd., Beijing Gingko Group, DSM NV., JXTG Nippon Oil & Energy Corporation, Algaecan Biotech Ltd, Griffon Corporation Inc. and Stanley Black & Decker Inc.
In October 2020, Cyanotech Corporation launched a water-dispersible powder form of BioAstin, available in both 1% and 2% concentrations. It is free-flowing and dispersible in either hot or cold water.
In May 2019, Algatech LTD has launched a micro-encapsulated natural astaxanthin powder that is formulated for vision and brain health. This would help the company cater to new segments, strengthening its market presence.
All the customers of this report will be entitled to receive one of the following free customization options: